HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Prilosec OTC Soothes P&G First Quarter Forecast As Early Shipments Rollout

This article was originally published in The Tan Sheet

Executive Summary

Stronger than expected initial orders for Prilosec OTC are responsible in part for Procter & Gamble's increase in its first quarter earnings guidance for fiscal year 2004

You may also be interested in...



GSK, Galpharm Pioneer UK Nonprescription Omeprazole Market

Galpharm Healthcare will launch a nonprescription omeprazole product under the name Galpharm Heartburn Relief in the UK "shortly," according to a spokesperson for the British firm

Zantac 75 Ad Comparison to Prilosec OTC Needs Revision, NAD Concludes

Ad claims for Pfizer's Zantac 75 that compare the H2 antagonist to Procter & Gamble's Prilosec OTC should be modified so consumers understand the heartburn remedies have different indications, the National Advertising Division of the Council for Better Business Bureaus concludes following a recent inquiry

Prilosec OTC Demand Taxing P&G Supply Chain Efficiency

Procter & Gamble is addressing shortfalls in its supply chain in order to meet higher than expected customer demand for Prilosec OTC

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS129802

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel